Diltiazem vs. nifedipine in chilblains: a clinical trial.
Indian J Dermatol Venereol Leprol
;
2003 May-Jun; 69(3): 209-11
Artigo
em Inglês
| IMSEAR
| ID: sea-52591
ABSTRACT
BACKGROUND:
The treatment of chilblains remains unsatisfactory. Nifedipine in higher doses remains the mainstay of treatment.AIMS:
To compare the efficacy of diltiazem with that of nifedipine, and to determine the efficacy of nifedipine in lower doses, 36 chilblains cases were studied. MATERIAL ANDMETHODS:
Group A (12 patients) was treated with diltiazem 60 mg thrice daily, and Group B (24 patients) with 10 mg nifedipine thrice daily till complete relief and then maintained on a sustained release preparation of nifedipine 20 mg twice daily.RESULTS:
Two patients in Group A showed complete relief in 7 days, and 3 patients in about 21 days, but in 7 cases there was little or no response. In group B, 21 cases showed 80-90% relief by the fourteenth day.CONCLUSIONS:
We conclude that nifedipine remains the drug of choice in chilblains but can be used in a smaller dosage in the Indian population. Diltiazem is less effective in the conventional dose, which may be optimized.
Texto completo:
DisponíveL
Índice:
IMSEAR (Sudeste Asiático)
Idioma:
Inglês
Revista:
Indian J Dermatol Venereol Leprol
Ano de publicação:
2003
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS